RG
BNTX icon

Redmile Group’s BioNTech BNTX Stock Holding History

Redmile Group’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-73,071
Closed -$6.65M – 51
2025
Q1 		$6.65M Sell
73,071
-10,400
-12% -$1.16M 0.63% 31
2024
Q4 		$9.51M Sell
83,471
-70,985
-46% -$8.1M 0.66% 33
2024
Q3 		$18.3M Buy
+154,456
New +$14.2M 1.08% 31
2021
Q1 		– Sell
-580,746
Closed -$47.3M – 89
2020
Q4 		$47.3M Sell
580,746
-654,899
-53% -$64.3M 0.57% 48
2020
Q3 		$85.5M Sell
1,235,645
-1,833,519
-60% -$132M 1.57% 19
2020
Q2 		$205M Buy
3,069,164
+2,898,964
+1,703% +$145M 3.78% 7
2020
Q1 		$9.94M Sell
170,200
-3,300
-2% -$128K 0.28% 54
2019
Q4 		$5.88M Buy
+173,500
New +$3.89M 0.14% 58

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Redmile Group's BNTX Position: Q2 2025 in Review

Redmile Group sold out of BioNTech (BNTX) in Q2 2025, closing a stake of 73,071 shares — an estimated $6.65M sold.

Redmile Group first reported a position in BNTX in Q4 2019 and held it in 8 quarters. The position peaked at $205M in Q2 2020. 258 funds tracked by Wall St. Rank hold BNTX as of Q2 2025.

  • Redmile Group reported no remaining BioNTech position as of Q2 2025 after selling out during the quarter.
  • Redmile Group sold 73,071 BioNTech shares in Q2 2025, an estimated $6.65M.
  • Redmile Group first reported a position in BioNTech in Q4 2019 and held it in 8 quarters.
  • Redmile Group's BioNTech position peaked at $205M in Q2 2020.
  • 258 funds tracked by Wall St. Rank held BioNTech as of Q2 2025.

Based on Redmile Group's 13F filing for Q2 2025, filed 14 Aug 2025.